GlassScriptPhysician profile
Mehar Kaur Brar
NPI 1255004511
$2,875.38
in general payments reported to CMS, 2019-2025
11 companies · $495 in 2025
The $495 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $43.41 · 2023: $260 · 2024: $2,077 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,647 · Travel and Lodging: $1,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,647.41 |
| Travel and Lodging | $1,184.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,576.05 | 2024 | Axonics, Bulkamid |
| Medtronic, INC. | $484.06 | 2022-2025 | Interstim |
| Sumitomo Pharma America, INC. | $334.97 | 2023-2025 | Gemtesa |
| Abbvie INC. | $158.75 | 2025 | |
| Pharming Healthcare, INC. | $124.99 | 2024 | Joenja |
| Astellas Pharma US INC | $48.40 | 2024 | Veozah, Myrbetriq |
| Valencia Technologies Corporation | $47.57 | 2023-2025 | Ecoin Device Kit |
| Integra Lifesciences Corporation | $44.64 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Urovant Sciences INC | $25.54 | 2022 | |
| Laborie Medical Technologies Corp. | $20.64 | 2025 | |
| Boston Scientific Corporation | $9.77 | 2025 | Bulkamid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehar Brar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.